MAGE-A1-derived peptide

This MAGE-A1-derived peptide is a tumor-specific antigen that activates cytotoxic T lymphocytes (CTLs) to target and lyse MAGE-A1-expressing cancer cells. It is widely used in cancer immunotherapy research, including in vitro T-cell activation assays and in vivo preclinical studies of antitumor immune responses.